COVID-19 vaccine associated demyelination & its association with MOG antibody

BACKGROUND: ChAdOx1-S (Covishield™/Vaxzervria, AstraZeneca) and BBV152 (Covaxin) SARS-CoV-2 vaccines are proven to be safe and effective, but rare complications have been reported. OBJECTIVE: To describe reports of central nervous system (CNS) demyelination following ChAdOx1-S and BBV152 vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Netravathi, M., Dhamija, Kamakshi, Gupta, Manisha, Tamborska, Arina, Nalini, A., Holla, V.V., Nitish, L.K., Menon, Deepak, Pal, P.K., Seena, V., Yadav, Ravi, Ravindranadh, M., Faheem, Arshad, Saini, J., Mahadevan, Anita, Solomon, Tom, Singh, Bhagteshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917969/
https://www.ncbi.nlm.nih.gov/pubmed/35306244
http://dx.doi.org/10.1016/j.msard.2022.103739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917969/
https://www.ncbi.nlm.nih.gov/pubmed/35306244
http://dx.doi.org/10.1016/j.msard.2022.103739

Ejemplares similares